Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Project Grant - PA: Pandemic Preparedness and Health Emergencies Research

University of Ottawa

$750,000.00

Characterization of filovirus host factors and small-molecule inhibitors of infection

FY 2022-23

Summary
Filoviruses are negative strand RNA viruses that can cause severe hemorrhagic fevers in human following zoonotic spillover events. Outbreaks of filovirus diseases are increasing in frequency and our knowledge of the Filoviridae family expended greatly recently with the discovery of new filoviruses in Europe, Africa and Asia that are also potentially pathogenic. While a vaccine against Ebola virus, one of the 5 species of ebolaviruses, is available, it does not protect well against all ebolaviruses and does not protect against other pathogenic filoviruses. Therefore, pan-filoviral antiviral therapy is urgently needed. In this proposed project, we aim to gain a molecular understanding of the filovirus-host cell interactions with the overarching goal of identifying and characterizing pan-filovirus small molecule inhibitors for the development of new pan-filoviral antiviral therapies.
Program
Project Grant - PA: Pandemic Preparedness and Health Emergencies Research
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
473350
Name
Côté Marceline
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Virology & Viral Pathogenesis
Projecttitle
Characterization of filovirus host factors and small-molecule inhibitors of infection
Programtype2
Operating Grants
Orgnameinp2
University of Ottawa
Cihramount2
$750,000
Cihrequipment2
$0
Programname2
Project Grant - PA: Pandemic Preparedness and Health Emergencies Research
Keyworddelim
Filovirus; Genome Editing; Macrophages; Neutralizing Antibodies; Small-Molecule Inhibitors; Vesicular Trafficking; Viral Entry; Viral Fusion Proteins
Abstract
Filoviruses are negative strand RNA viruses that can cause severe hemorrhagic fevers in human following zoonotic spillover events. Outbreaks of filovirus diseases are increasing in frequency and our knowledge of the Filoviridae family expended greatly recently with the discovery of new filoviruses in Europe, Africa and Asia that are also potentially pathogenic. While a vaccine against Ebola virus, one of the 5 species of ebolaviruses, is available, it does not protect well against all ebolaviruses and does not protect against other pathogenic filoviruses. Therefore, pan-filoviral antiviral therapy is urgently needed. In this proposed project, we aim to gain a molecular understanding of the filovirus-host cell interactions with the overarching goal of identifying and characterizing pan-filovirus small molecule inhibitors for the development of new pan-filoviral antiviral therapies.
Competitiondate
202209
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Côté, Marceline
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $750,000~ $0~